In the Penn North neighborhood of Baltimore, the terror of a mass overdose is a visceral memory. Last year alone, the area saw three such incidents in just three months, including one where over two dozen people were rushed to hospitals after falling unresponsive on city sidewalks. Investigators discovered that the street drugs were laced with N-methylclonazepam, a potent benzodiazepine that suppresses breathing much like opioids do, but with a deadly twist: it does not respond to naloxone, the standard overdose reversal drug. In response, the Baltimore Harm Reduction Coalition began flooding the community with free test strips, placing them in bars and on street corners so users could identify dangerous additives before taking a dose.
However, a shift in federal policy is now threatening the availability of these life saving tools. The Substance Abuse and Mental Health Services Administration recently banned the use of federal grants for distributing test strips to the public, alongside other harm reduction efforts like providing clean needles or operating safety hotlines. According to communications sent to local health departments, the current administration argues that these practices facilitate illegal drug use and conflict with federal laws. While federal funds can still be used for test strips handled by police or medical professionals, advocates argue that putting the power of detection directly into the hands of users is what actually prevents fatalities.
Critics of the ban point to evidence showing that when people know exactly what is in their drugs, they often choose to use less or avoid certain substances entirely. For leaders like Candy Kerr of the Baltimore Harm Reduction Coalition, this isn’t about encouraging drug use but about survival. She notes that Baltimore has seen overdose deaths drop by more than 40 percent since 2023, a success she attributes to a comprehensive approach that combines medication distribution with proactive testing. To her, removing federal funding ignores the reality of how people navigate addiction on the street.
Despite the loss of grant money, organizations like Kerr’s refuse to stop distributing tests because they believe any alternative is too risky. This determination comes at a steep price; without federal support, nonprofits must divert money from other essential services to cover costs. In Baltimore’s case, this means cutting back on hygiene and wound care kits for vulnerable populations. It is a difficult trade off, but for those fighting on the front lines of the crisis, sacrificing bandages is a necessary price to pay to prevent another mass casualty event on their doorsteps.
